MONTREAL, July 3 /PRNewswire/ -- XMT Liquidations Inc. (XMT), the court appointed liquidator of 6356095 Canada Inc. (formerly Excapsa Software Inc.), announces that it has received the requisite clearance from the Canada Revenue Agency in connection with the payment of a US $10 million capital gains dividend to registered shareholders. 6356095 Canada Inc. currently has 194,880,883 outstanding shares. Accordingly, registered shareholders will receive US $0.0513 per share. XMT anticipates that the capital gains dividend will be paid within the next 30 days. The payments will be made in US dollars. As payments will be made to registered shareholders only, beneficial holders are encouraged to contact their brokers to arrange for delivery of funds. For further information: Sheldon W. Krakower, XMT Liquidations Inc. c/o WSBG L.L.P., 1155 René Lévesque West, Suite 2010, Montréal, Québec, H3B 2J8, Telephone: +1-(514)-861-9724, Direct: +1-(514)-315-3674, skrak@wsbg.com/ SOURCE: 6356095 Canada Inc. For further information: Sheldon W. Krakower, XMT Liquidations Inc. c/o WSBG L.L.P., 1155 René Lévesque West, Suite 2010, Montréal, Québec, H3B 2J8, Telephone: +1-(514)-861-9724, Direct: +1-(514)-315-3674, skrak@wsbg.com/
6356095 Canada Inc. (formerly Excapsa Software Inc.) To Pay Capital Gains Dividend
Related articles
- Excapsa's Liquidator Announces Settlement
- Mersana's Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics And Anti-Tumor Activity In Studies Presented At American Association Of Cancer Research Meeting
- Mersana Therapeutics Publishes Review Article Detailing Advantages Of Its Lead Cancer Compound In Journal Of Advanced Drug Delivery Reviews
- Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
- Mersana Therapeutics Reports Phase I Results For XMT-1001 In Patients With Solid Tumors At AACR-NCI-EORTC International Conferen
Comments